A new standard for objective food allergy care.
Veradyn Medical detects physiological signals of an allergic reaction before visible symptoms appear, giving clinicians the insight to act earlier and make food allergy care safer.
Our Mission
Our mission is to replace uncertainty in food allergy care with objective physiological insight. Veradyn is developing continuous monitoring technology that reveals the body's earliest signals of an allergic reaction, helping clinicians act sooner and provide safer, more confident care.
We believe objective physiological monitoring can help establish a new standard of care for allergy medicine.
The impact extends beyond the test itself. Earlier, more objective insight can help patients get clearer answers, reduce unnecessary food avoidance, and make confirmatory testing safer and more efficient for clinicians.
Our Team
Veradyn Medical brings together expertise in allergy medicine, biomedical sensing, and medical-device commercialization.
Matt Weber
CEO, Co-Founder
Medical-device executive with experience bringing Class I and Class II products from development through commercialization. Leads Veradyn’s product strategy, company development, and execution.
Chase Schuler, M.D.
CMO, Co-Founder
Practicing allergist and physician-scientist whose research identified the relationship between transepidermal water loss and allergic reactions. Leads Veradyn’s clinical strategy and development.
Sherman Fan, Ph.D.
Tech Advisor, Co-Founder
Biomedical engineer and inventor of the continuous TEWL sensing platform underlying Veradyn’s technology. Provides technical leadership in sensing, instrumentation, and platform development.
